Logo do repositório
 
Publicação

Disease and treatment patterns for advanced cholangiocarcinoma: A multicentric study from Portugal

dc.contributor.authorGonçalves, J. C. N.
dc.contributor.authorFreitas, A. R. R.
dc.contributor.authorFortuna, A. R.
dc.contributor.authorMenezes, M. B.
dc.contributor.authorGramaça, J.
dc.contributor.authorFernandes, I. C. Gomes
dc.contributor.authorAngelo, I. C.
dc.contributor.authorTrabulo, C. F. P.
dc.contributor.authorSousa, C. Xavier de
dc.contributor.authorPina, I. M. Matos
dc.date.accessioned2024-11-05T11:34:45Z
dc.date.available2024-11-05T11:34:45Z
dc.date.issued2024-06
dc.description.abstractMeeting Gastrointestinal Cancers Congress of the European-Society-for-Medical-Oncology (ESMO) Background: Gemcitabine plus cisplatin (GC) was standard first-line treatment for advanced biliary tract cancers until recently, supported by the UK ABC-02 study. However, TOPAZ-1 showed survival improvement with Durvalumab plus GC. Nevertheless, a significant proportion of patients face challenges with GC tolerability, prompting into alternatives such as gemcitabine and carboplatin (GCb). Moreover, there remains a paucity of stratified data pertaining to cholangiocarcinomas (CCA). We analyzed 5-year trends to determine treatment rates and cisplatin use in the real world.eng
dc.identifier.doi10.1016/j.annonc.2024.05.456
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/10400.1/26205
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.rights.uriN/A
dc.titleDisease and treatment patterns for advanced cholangiocarcinoma: A multicentric study from Portugaleng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPageS132
oaire.citation.issueSupl. 1
oaire.citation.startPageS131
oaire.citation.titleAnnals of Oncology
oaire.citation.volume35
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
313P Disease and treatment patterns for advanced cholangiocarcinoma_ A multicentric study from Portugal.pdf
Tamanho:
91.16 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
3.46 KB
Formato:
Item-specific license agreed upon to submission
Descrição: